RGT anti-a bcln 150ML mncln ABO GRP BB
Ended Awarded
- Contract number
- SPE2D326F246X
- Awardee
-
Quidelortho Sales Company, LLC UEI ZFXRG96JMJ39
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $1,018
Award facts
- Contract value 100% obligated
- $1,018.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Raritan, NJ 08869, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Health Agency's Medical Supply Chain issued a $1,018.08 delivery order to Quidelortho Sales Company, LLC, a HUBZone-certified joint venture, on July 8, 2026, for Roche anti-A blood banking reagent (150 mL minimum clean ABO group), with ultimate completion on July 9, 2026.
Place of performance is Raritan, NJ 08869. Pricing is firm fixed price under no set-aside.
Quick answers
Who was awarded contract SPE2D326F246X?
SPE2D326F246X was awarded to Quidelortho Sales Company, LLC by Medical Supply Chain (Troop Support) on July 8, 2026.
How much is contract SPE2D326F246X worth?
The government has obligated $1,018 on SPE2D326F246X.
Is contract SPE2D326F246X an order under another contract?
Yes. SPE2D326F246X is a delivery order under SPE2D018D0005, an indefinite delivery contract.
Was contract SPE2D326F246X competed?
The extent of competition for SPE2D326F246X was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award